Adding clopidogrel to aspirin does not reduce mortality for patients with drug-eluting coronary stents
Addition of clopidogrel to aspirin therapy does not reduce the rate of myocardial infarction or cardiac death among patients who have received drug-eluting coronary stents, according to a study published online in the New England Journal of Medicine (15 March 2010).
Some 2,700 patients, who had received such a stent and been free of cardiac or cerebrovascular events for at least 12 months, were randomised to receive aspirin and clopidogrel, or aspirin alone.
After two years, the cumulative risk of myocardial infarction or cardiac death was not significantly different between the two groups.
Citation: Clinical Pharmacist URI: 11004594
Recommended from Pharmaceutical Press